
KINSHASA, Congo (AP) — Congo on Monday announced the end of an Ebola outbreak that killed 43 people in one of the country's southern provinces, with authorities saying no new confirmed cases had been reported in the past 45 days.
Health Minister Roger Kamba said the 43 deaths were among 53 confirmed cases in the outbreak, which was first announced in September in the Kasai province town of Bulape. He said more than 27,000 people were vaccinated, including 4,000 front-line workers he credited with helping to stem the outbreak.
“Indeed, no new confirmed cases have been recorded for 45 consecutive days," Kamba said in the capital, Kinshasa.
The outbreak in Bulape, which spread to at least four neighboring towns, was the country's 16th since the disease first emerged in the Congo in 1976, and the 7th in Kasai province. The World Health Organization initially faced significant challenges in delivering the vaccine with limited access and scarce funds.
An Ebola outbreak from 2018 to 2020 in eastern Congo killed more than 1,000 people.
The latest outbreak added a fresh layer of worry for the Central African country, which has been battling the M23 rebel group, which launched a rapid assault in January in the eastern region of the country and has since occupied key cities.
LATEST POSTS
- 1
Instructions to Expand Your Advantages from an Open Record Reward - 2
Instructions to Utilize the Towing Highlights of the Slam 1500 Productively. - 3
Map shows more than 1,900 measles cases across U.S. - 4
Climate change is straining Alaska's Arctic. A new mining road may push the region past the brink - 5
South Carolina confirms 124 new measles cases as outbreak on the Arizona-Utah line grows
Netanyahu expects Iran's leadership to fall
7 Moves toward a Sound and Dynamic Way of life
Flat Earth, spirits and conspiracy theories – experience can shape even extraordinary beliefs
Architect Frank Gehry has died: See his most iconic buildings
AI’s errors may be impossible to eliminate – what that means for its use in health care
NASA’s Artemis II launch leaves Americans in awe: ‘We’re going to the frickin’ moon!’
Israel's ban on unsupervised reporters in Gaza causes strategic harm to legitimacy
Tesla Stock Hasn’t Looked This Cheap in a While
Agios Pharma shares jump as US FDA expands approval for its blood disorder drug












